Data from three terminally ill cardiogenic shock patients showcase potential of procizumab to safely reverse shock within 48 hours and p ...

In a new clinical practice guideline, the Endocrine Society advises universal screening of those with hypertension by ...

Endocrine Society experts encouraged more widespread screening for a common hormonal cause of high blood pressure known as ...

Endocrine Society experts encouraged more widespread screening for a common hormonal cause of high blood pressure known as ...

Coconut water, a natural electrolyte beverage, may help lower blood pressure. However, there's not much evidence to support ...

Lorundrostat (Mineralys Therapeutics), a novel aldosterone synthase inhibitor, can substantially lower blood pressure in patients with uncontrolled and treatment-resistant hypertension, according to ...

Current standard of care medications like ACE inhibitors and angiotensin receptor blockers target the renin-angiotensin-aldosterone system (RAAS), but their focus is primarily on the renin ...

Darcy Adin, DVM, DACVIM (Cardiology): So, RAAS is the renin‐angiotensin‐aldosterone system, and we call it RAAS cause it's easier to say that. It is a hormone system that is appropriately actived when ...

Background: Mounting experimental evidence supports the concept that the RAAS (renin-angiotensin-aldosterone system) is involved in the pathogenesis of intracranial aneurysm rupture. However, whether ...

Researchers conducted an umbrella review and meta-analysis of the RAAS inhibitors' impact on COVID-19 clinical outcomes.

Traditional MRA therapy for DKD has been spironolactone; however, renin-angiotensin-aldosterone system blockade therapy has been limited due to rising potassium levels often seen with such therapy ...